Skip to main content
. 2010 Jan;176(1):435–445. doi: 10.2353/ajpath.2010.090403

Figure 1.

Figure 1

IL-11, IL-11Rα, and GP130 mRNA expression. A: The relative mRNA expression of IL-11 in normal proliferative-phase endometrium (n = 10) and poorly (n = 10), moderately (n = 10), and well-differentiated (n = 10) endometrial adenocarcinoma as determined by real-time quantitative RT-PCR analysis. Data are represented as mean ± SEM proliferation is significantly different from poorly (*P < 0.001), moderately (**P = 0.005), and well-differentiated (***P = 0.02) adenocarcinomas compared with proliferative-phase endometrium; ANOVA posttest for linear trend for IL-11 expression between poorly, moderately, and well-differentiated adenocarcinomas, ****P < 0.0001. The relative mRNA expression of IL-11Rα (B) and GP130 (C) in normal proliferative-phase endometrium (n = 10) and poorly (n = 10), moderately (n = 10), and well-differentiated (n = 10) endometrial adenocarcinoma as determined by real-time quantitative RT-PCR analysis. Data are represented as mean ± SEM proliferation is significantly different from poorly (*P = 0.03), moderately, and well-differentiated (**P = 0.04) adenocarcinomas compared with proliferative-phase endometrium.